BioStem Technologies, Inc. Shareholders' Equity
BioStem Technologies, Inc. (BSEM) had Shareholders' Equity of $27.61 million as of 2026-06-30, per its S-1 filed 2026-09-18.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-18
- 2026-06-30: Stockholders' Equity Attributable to Parent $27.61M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $31.87M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $39.14M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $47.23M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $27.61M S-1 · filed 2026-09-18 |
| 2026-03-31 | $31.87M S-1 · filed 2026-09-18 |
| 2025-12-31 | $39.14M S-1 · filed 2026-09-18 |
| 2025-06-30 | $47.23M S-1 · filed 2026-09-18 |
| 2025-03-31 | $46.09M S-1 · filed 2026-09-18 |
| 2024-12-31 | $40.02M S-1 · filed 2026-09-18 |
| 2023-12-31 | -$1.34M S-1 · filed 2026-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |